Diarrhea, nausea, vomiting, skin rashes, urticaria.
Powd for inj Mucocutaneous candidiasis; leukopenia (including neutropenia) & thrombocytopenia, agranulocytosis & anemia hemolytic; angioneurotic edema, anaphylaxis, serum sickness-like syndrome, hypersensitivity vasculitis, interstitial nephritis, crystalluria; dizziness, hyperactivity & seizures in patients w/ impaired kidney function or use w/ high doses; inj site thrombophlebitis; indigestion, antibiotic-associated colitis (including pseudomembranous colitis & haemorrhagic colitis), black hairy tongue & superficial tooth discoloration in childn; slight increases in AST &/or ALT; incident hepatic disease associated w/ long-term therapy.